Could immune cells be key to chronic migraine?
NCT ID NCT07067112
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a type of immune cell called regulatory T cells works properly in people with chronic migraine. Researchers will compare blood samples from 24 women with chronic migraine to healthy controls. The goal is to understand if problems with these cells contribute to migraine pain, which could lead to new treatment ideas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could point toward new treatments that target immune system problems in chronic migraine.
- What could go wrong
- This is a small, early observational study with only 24 participants, so results may not apply broadly. It aims to understand the disease, not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Clermont-Ferrand
Clermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can neck exercises turn down the volume on chronic migraine?
- Can a No-Fridge migraine shot replace botox?
- Could a common cholesterol drug stop chronic migraine?
- Migraine relief may sharpen the mind: study investigates cognitive benefits of preventive therapies
- New combo therapy for chronic migraine: atogepant plus botox under study
- Thousands to test new migraine meds in largest Real-Life study